Therapeutic systems research laboratories (tsrl), inc. Is a privately women-owned, pre-clinical accelerator based in ann arbor, michigan focused on building companies that develop infectious disease therapeutics. A key aspect of our strategy is our technology accelerator, an ongoing collaborative process that lends our expertise and capabilities to entrepreneurs seeking to obtain the data and non-dilutive funding necessary to develop and/or commercialize their inventions. One focus is improving existing drug products by applying our versatile prodrug platform technologies to optimize therapy regimen for treating infectious diseases. Potential target indications include: influenza, hsv, vzv, cmv, ebv, poxvirus, hpv, adenovirus, and rna viruses. We currently employ ten full-time employees and a number of drug development consultants and generate annual revenues of approximately $2m from royalties and grants.